Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-09

Clinical Trial Update: Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors

View source ↗

Summary

Clinical trial update examining the impact of eslicarbazepine acetate on lipid metabolism and cardiovascular risk factors in epilepsy patients. The current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Epilepsy | Status: UNKNOWN